深度解析医学证据，DeepEvidence为你支撑决策
2026年5月24-27日，第94届欧洲动脉粥样硬化学会年会（EAS 2026）将在希腊雅典盛大举办。随着肥胖逐渐成为全球心血管与代谢疾病防控的重要议题，肥胖相关研究已成为本届大会的重要热点之一。从GLP-1信号通路、双/三靶点肠促胰素治疗，到脂肪组织功能、炎症反应、代谢调控及真实世界管理策略，大量前沿研究集中亮相。司美格鲁肽等创新减重治疗持续受到关注，肥胖与动脉粥样硬化、糖脂代谢异常及炎症风险之间的复杂关联也迎来更多机制探索。POCKETIN特别梳理EAS 2026肥胖领域重点日程，带您抢先聚焦代谢健康管理的最新突破与未来方向。
05月25日
SaaG Session: Cellular LDL Handling and Intracellular Lipid Metabolism
北京时间：19:12
THE ROLE OF APOLIPOPROTEIN A2 IN LIPOPROTEIN METABOLISM, DEVELOPMENT OF OBESITY, AND CARDIOVASCULAR DISEASE
载脂蛋白A2在脂蛋白代谢、肥胖发生及心血管疾病中的作用
Konstantinos Marinos (Greece)
SaaG Session: Systemic Lipid and Lipoprotein Metabolism in Cardiovascular Disease
北京时间：19:49
LONG-ACTING GLUCAGON RECEPTOR AGONISM INCREASES CIRCULATING TRIGLYCERIDE LEVELS IN DIET-INDUCED OBESE MICE
长效胰高血糖素受体激动作用增加饮食诱导肥胖小鼠的循环甘油三酯水平
Jamie I. Van der Vaart (Netherlands)
SaaG Session: Metabolic Dysregulation and Dyslipidemia Across the Cardiometabolic Spectrum
北京时间：20:10
ASSOCIATION OF 3D-BODY-SCAN-DERIVED MEASURES OF OBESITY AND SUBCLINICAL ATHEROSCLEROSIS
基于3D全身扫描的肥胖与亚临床动脉粥样硬化指标的关联
Amalie Dufva (Denmark)
SaaG Session: Obesity, Nutrition and Metabolic Drivers of Vascular Disease
北京时间：19:35
VISCERAL ADIPOSE TISSUE MEASURED BY DXA PREDICTS MAJOR CARDIOVASCULAR EVENTS AND CARDIOVASCULAR MORTALITY IN US ADULTS
通过DXA测量的内脏脂肪组织可预测美国成年人主要心血管事件和心血管死亡率
Arturo Cesaro (Italy)
北京时间：19:42
ULTRADIAN CYCLES IN MICE AFFECT GLUCOSE LEVELS INDEPENDENTLY OF FOOD INTAKE
小鼠中的超日节律独立于食物摄入影响葡萄糖水平
Magdaléna Vydrová (Czech Republic)
北京时间：19:49
IMMUNE RECONSTITUTION IN SURVIVORS FROM CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) ASSOCIATES WITH AN ALTERED IMMUNO-METABOLIC PROFILE AND VASCULAR DYSFUNCTION.
儿童急性淋巴细胞白血病幸存者的免疫重建与改变的免疫代谢特征及血管功能障碍相关
Marta Iaia (Italy)
北京时间：19:56
UK REAL-WORLD EXPERIENCE WITH BEMPEDOIC ACID IN DYSLIPIDAEMIA: 1-YEAR RESULTS FROM THE MILOS STUDY
英国真实世界中贝派地酸治疗血脂异常的经验：MILOS研究的1年结果
Kausik K. Ray (United Kingdom)
北京时间：20:03
UTILISING BEMPEDOIC ACID FOR SECONDARY ASCVD PREVENTION IN A RURAL PRIMARY CARE PRACTICE: REAL-WORLD LDL-C OUTCOMES, ADHERENCE, AND CLINICIAN STRATEGIES SUPPORTING TREATMENT PERSISTENCE
在农村初级保健实践中利用贝派地酸进行ASCVD二级预防：真实世界LDL-C结局、依从性及支持治疗持续性的临床策略
Meredith Donaldson (United Kingdom)
北京时间：20:10
HYPERCHOLESTEROLEMIA EXACERBATES RHEUMATOID ARTHRITIS AND PROMOTES METABOLIC MACROPHAGE ACTIVATION IN APOE DEFICIENT MICE WHICH IS REVERSED BY SIMVASTATIN TREATMENT
高胆固醇血症加重类风湿关节炎，并促进ApoE缺陷小鼠中代谢性巨噬细胞活化，辛伐他汀治疗可逆转这一过程
Dimitris Kardassis (Greece)
05月26日
New insights into CKM and Obesity (Tackling obesity to prevent ASCVD)
北京时间：15:30
GLP-1 signalling in cardiometabolic and renal disease
GLP-1信号在心脏代谢及肾脏疾病中的作用
Anna Solini (Italy)
北京时间：15:50
Pleiotropic effects of dual and triple incretins on metabolic health
双靶点及三靶点肠促胰素对代谢健康的多效性作用
Thomas Lutz (Switzerland)
北京时间：16:10
PREGNANCY COMPLICATIONS AND RISK OF CHRONIC KIDNEY DISEASE
妊娠并发症与慢性肾脏病风险
Rikke Mohr Lytsen (Denmark)
北京时间：16:20
A PROTEO-GENOMIC ANALYSIS OF THE LIVER IDENTIFIES NEW POTENTIAL THERAPEUTIC TARGETS FOR TYPE 2 DIABETES
肝脏的蛋白质-基因组分析识别出2型糖尿病的新潜在治疗靶点
Valérie C?té (Canada)
北京时间：16:30
SEMAGLUTIDE SIGNIFICANTLY REDUCES BONE MARROW RESIDENT INFLAMMATORY MACROPHAGES AND CIRCULATING INFLAMMATORY MONOCYTES IN T2D PATIENTS
司美格鲁肽显著减少2型糖尿病患者骨髓内驻留的炎症性巨噬细胞及循环中的炎症性单核细胞
Thomas J. Collins (Netherlands)
北京时间：16:40
PREVALENCE OF HIGH INFLAMMATORY RISK IN ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WITH AND WITHOUT CHRONIC KIDNEY DISEASE: FINDINGS FROM POSEIDON – A GLOBAL CROSS-pAL PREVALENCE STUDY
伴或不伴慢性肾脏病的动脉粥样硬化性心血管疾病中高炎症风险的患病率：POSEIDON研究的结果——一项全球横断面患病率研究
Ann Marie Navar (United States of America)
北京时间：16:50
SYSTEMIC METABOLIC DISORDER STAGING TO ESTIMATE GLOBAL AND ORGAN-SPECIFIC DISEASE RISK IN THE GENERAL POPULATION
系统代谢紊乱分期以评估普通人群的总体及器官特异性疾病风险
Stefano Romeo (Sweden)
SaaG Session: Immune Cell Phenotypes and Inflammatory Signatures in Cardiovascular Disease
北京时间：18:51
SERUM CHEMERIN AND CHEMERIN EXPRESSION IN PERIVASCULAR ADIPOSE TISSUE REFLECT OBESITY-RELATED INFLAMMATION AND ATHEROSCLEROSIS-ASSOCIATED VASCULAR REMODELING IN PATIENTS UNDERGOING CORONARY ARTERY BYPASS SURGERY
血清Chemerin及其在血管周围脂肪组织中的表达反映接受冠状动脉旁路移植术患者中肥胖相关炎症及动脉粥样硬化相关血管重塑
Ning Xia (Germany)
Lipoprotein remnants and metabolic disease
北京时间：21:45
SEMAGLUTIDE AND EXERCISE SYNERGY IN OBESITY: PRESERVING MUSCLE MASS AND UNCOVERING ORGAN CROSSTALK
司美格鲁肽与运动在肥胖中的协同作用：保持肌肉质量与揭示器官间交叉对话
Jose Inia (Netherlands)